Back to
Invesco Ltd.
CAPR
Showing 8 of 9 quarters
Position history for
Invesco Ltd.'s holdings in Capricor Therapeutics, Inc.
Yes. Invesco holds 29,552 shares of CAPR (Capricor Therapeutics), worth $711,612, as of its Q2 2026 13F filing. It reduced the position by 155,820 shares (-84.1%) from Q1 2026. Invesco has held CAPR since Q2 2024, across 9 quarterly 13F filings.
Current Value
$711,612
Current Shares
29,552
Total Value Change
+$526,385
Total Shares Change
+17,374
Quarter-by-Quarter History